Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
M1 Kliniken AGMKLNF 92 ROC (Joel Greenblatt) % is 176.90% as of Dec. 2025, which is 233% above its 10-year median of 53.08. GuruFocus rates MKLNF with a GF Score™ of 92/100 and a GF Value™ of $10.32. The stock has 2 warning signs investors should review. Among 118 Medical Distribution companies, M1 Kliniken AG ranks better than 97.46% on this metric.
Joel Greenblatt defined Return on Capital differently in his book The Little Book That Still Beats the Market (Little Books. Big Profits). He defines ROC (Joel Greenblatt) % as EBIT divided by the total of Property, Plant and Equipment and net working capital. M1 Kliniken AG's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2025 was 176.90%.
The historical rank and industry rank for M1 Kliniken AG's ROC (Joel Greenblatt) % or its related term are showing as below:
MKLNF'
s ROC (Joel Greenblatt) % Range Over the Past 10 Years
Min: 31.93 Med: 53.08 Max: 149.13
Current: 149.13
During the past 12 years, M1 Kliniken AG's highest ROC (Joel Greenblatt) % was 149.13%. The lowest was 31.93%. And the median was 53.08%.
MKLNF's ROC (Joel Greenblatt) % is ranked better than 97.46% of 118
companies
in the Medical Distribution industry
Industry Median: 16.185
vs MKLNF: 149.13
M1 Kliniken AG's 5-Year average Growth Rate of ROC (Joel Greenblatt) % was 28.10% per year.
M1 Kliniken AG (OTCPK:MKLNF) ROC (Joel Greenblatt) % Explanation
The way Joel Greenblatt defines Return on Capital is a more accurate measure of how efficiently the company generates returns onthe capital actually invested in the business. EBIT is used instead of net income because the tax and interest payment may be affected by factors other than the core business operation. Intangible assets are not included in the calculation because they don't need to be replaced.
M1 Kliniken AG ROC (Joel Greenblatt) % Related Terms
M1 Kliniken AG ROC (Joel Greenblatt) % Historical Data
* Premium members only.
The historical data trend for M1 Kliniken AG's ROC (Joel Greenblatt) % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
MKLNF vs MCK, CAH, COR: ROC (Joel Greenblatt) % Comparison
For the Medical Distribution subindustry, M1 Kliniken AG's ROC (Joel Greenblatt) %, along with its competitors' market caps and ROC (Joel Greenblatt) % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
M1 Kliniken AG ROC (Joel Greenblatt) % vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, M1 Kliniken AG's ROC (Joel Greenblatt) % distribution charts can be found below:
* The bar in red indicates where M1 Kliniken AG's ROC (Joel Greenblatt) % falls into.
M1 Kliniken AG ROC (Joel Greenblatt) % Calculation
Joel Greenblatt defined Return on Capital differently in his book The Little Book That Still Beats the Market (Little Books. Big Profits) . He defines Return on Capital as follows:
EBIT stands for Earnings Before Interest and Taxes.
Fixed Assets are also known as non-current assets. They include the Property, Plant and Equipment that the firm needs in its operation.
GuruFocus calculates net working capital as: (Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Deferred Revenue + Other Current Liabilities). We're trying to account for OPERATING assets and liabilities (part of daily business) when calculating working capital. Cash and marketable securities are considered NON-OPERATING assets and are not included in calculation. We will also back out all interest bearing debt, short term debt and the portion of long term debt that is due in the current period from the current liabilities. This debt will be considered when computing cost of capital and it would be inappropriate to count it twice.
Note:
The EBIT data used here is two times the semi-annual (Dec. 2025) EBIT data.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a ROC (Joel Greenblatt) % of 176.90% mean?
M1 Kliniken AG (MKLNF) has a ROC (Joel Greenblatt) % of 176.90% as of Dec. 2025. Joel Greenblatt's return on capital is the ratio of EBIT to average fixed assets and net working capital. View historical data on M1 Kliniken AG and its competitors. This is 233% above median its historical median of 53.08. Over the past decade, M1 Kliniken AG's ROC (Joel Greenblatt) % has ranged from 31.93 to 149.13. According to the industry distribution chart, M1 Kliniken AG ranks #3 out of 118 companies in the Medical Distribution industry, placing it in the top 2.5%.
Is M1 Kliniken AG's ROC (Joel Greenblatt) % too high?
M1 Kliniken AG's current ROC (Joel Greenblatt) % of 176.90% is 233% above median its 10-year median of 53.08. Over the past 10 years, this metric has ranged from a low of 31.93 to a high of 149.13. The Medical Distribution industry median ROC (Joel Greenblatt) % is 16.19. M1 Kliniken AG's value of 176.90% is 993% above this industry median. Based on the distribution chart, M1 Kliniken AG ranks #3 out of 118 companies in the Medical Distribution industry, which is in the top quartile — a strong position relative to peers. Overall, M1 Kliniken AG has a GF Score™ of 92/100, reflecting its overall financial health beyond just this single metric.
How does M1 Kliniken AG's ROC (Joel Greenblatt) % compare to MCK and CAH?
According to the Medical Distribution industry distribution chart, M1 Kliniken AG ranks #3 out of 118 companies for ROC (Joel Greenblatt) %. This places M1 Kliniken AG in the top 3% of its industry — outperforming the majority of peers. The industry median ROC (Joel Greenblatt) % is 16.19. M1 Kliniken AG's value of 176.90% is 993% above this benchmark. Historically, M1 Kliniken AG's own ROC (Joel Greenblatt) % has ranged from 31.93 to 149.13 over the past decade. While the company's 10-year median is 53.08 vs. the industry median of 16.19, M1 Kliniken AG has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROC (Joel Greenblatt) % for a Medical Distribution company?
The median ROC (Joel Greenblatt) % among Medical Distribution companies is 16.19, based on 118 companies in the industry. Companies in the top quartile (top 25%) have a ROC (Joel Greenblatt) % significantly above this median, while those in the bottom quartile fall well below. However, ROC (Joel Greenblatt) % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. M1 Kliniken AG's current ROC (Joel Greenblatt) % of 176.90% is 993% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROC (Joel Greenblatt) % mean?
A high ROC (Joel Greenblatt) % can signal that a stock is expensive relative to its fundamentals. Joel Greenblatt's return on capital is the ratio of EBIT to average fixed assets and net working capital. View historical data on M1 Kliniken AG and its competitors. For the Medical Distribution industry, the median ROC (Joel Greenblatt) % is 16.19 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. M1 Kliniken AG's current ROC (Joel Greenblatt) % is 176.90%, which is 233% above median its own 10-year median of 53.08. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is M1 Kliniken AG stock overvalued right now?
M1 Kliniken AG (MKLNF) has a current ROC (Joel Greenblatt) % of 176.90%. The stock's GF Value™ is $10.32, compared to a current price of $11.73 — trading 13.6% above its estimated fair value. The current ROC (Joel Greenblatt) % is 176.90%, which is 233% above median its 10-year median of 53.08 and 993% above the Medical Distribution industry median of 16.19. M1 Kliniken AG's overall GF Score™ is 92/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROC (Joel Greenblatt) % calculated?
ROC (Joel Greenblatt) % is calculated from a company's financial statements. For M1 Kliniken AG (MKLNF), the current ROC (Joel Greenblatt) % is 176.90% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is M1 Kliniken AG (MKLNF) Overvalued in 2026?
Based on GuruFocus' analysis, M1 Kliniken AG stock appears to be overvalued.
The current stock price of $11.73 is trading 13.6% above its estimated GF Value™ of $10.32.
Key valuation signals for MKLNF:
ROC (Joel Greenblatt) %: 176.90% (233% above median its 10-year median of 53.08)
GF Value™: $10.32 vs. price of $11.73 (13.6% above fair value)
Industry Position: 993% above the Medical Distribution median (#3 of 118)
No single metric tells the full story. See the MKLNF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
M1 Kliniken AG operates in the growing market of aesthetic medicine and plastic surgery and provides aesthetic medical treatments in the self-pay segment. It operates through Beauty and Trade segments. Its activities are focused on providing aesthetic medical treatment. In addition to medical aesthetic treatments, the company also develops and markets pharmaceutical, medical, and medical technology products for aesthetic surgery and cosmetic dermatology. Some of the treatments offered by the group are lip under injection, eyebrow lift, tummy tuck, breast reduction, sweat treatment, liposuction, and others. The organization conducts its business operations in Germany. The majority of its revenue is derived from the Trade segment.
92GF Score
Get the complete analysis for MKLNF
ROC (Joel Greenblatt) % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MKLNF has been successfully added to your 
